- Retraction Note
- Open Access
Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer
World Journal of Surgical Oncologyvolume 17, Article number: 105 (2019)
The original article was published in World Journal of Surgical Oncology 2015 13:195
Retraction note: World J Surg Oncol
None of the authors have responded to any correspondence from the Editor-in-Chief or publisher about this retraction.
Kai Y, Qiang C, Xinxin P, Miaomiao Z, Kuailu L. Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol. 2015;13:195.
Zhu, et al. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol. 2014;(9):198 http://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-014-0198-4.
Fo, et al. MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. OncoTargets and Therapy. 2014;7 https://www.dovepress.com/front_end/mir-206-functions-as-a-tumor-suppressor-and-directly-targets-k-ras-in%2D%2Dpeer-reviewed-article-OTT.
Tang M, et al. MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. OncoTargets Therapy. 2013;6:833–8 https://www.dovepress.com/microrna-145-downregulation-associates-with-advanced-tumor-progression-peer-reviewed-article-OTT.
Ye, et al. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal Cancer. Plos One. 2013. https://journals.plos.org/plosone/article?id. https://doi.org/10.1371/journal.pone.0060687.
Sun, et al. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. Biomed Pharmacother. 2015;71:58–63 http://www.sciencedirect.com/science/article/pii/S0753332215000633?np=y&npKey=36a5e61c240440f5c791ebb330c69e53b99cf4b599d8cf35805ed8498bb593a4.